US regulator alleges Dr Reddy's breached packaging rules

Tags: Companies
Export-focused drugmaker Dr Reddy's Laboratories Ltd said it was in talks with a US regulator over allegations it violated packaging rules for some prescription drugs sold there between 2008 and 2012.

The allegations by the U.S. government's Consumer Product Safety Commission (CPSC) are the latest in a series of regulatory troubles facing Indian pharmaceutical firms in their biggest export market, the United States.

In a U.S. stock exchange filing this week, Dr Reddy's said the CPSC planned to seek civil penalties against the company for allegedly violating rules intended to prevent children from ingesting harmful substances.

The company said any unfavourable outcome could result in "significant liabilities" and added that it disagreed with the allegations.

Indian drugmakers have suffered a string of drug recalls and manufacturing quality-related issues that have hurt the reputation of the $15 billion-a-year industry as a supplier of cheap generic drugs, and led to increased scrutiny from regulators.


  • The govt should build on the feel good season to bolster its economic agenda

    There are two pieces of good news to ring in the festive season beginning this Dusshera.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Sachin Shridhar

Reordering the world order on cheap money

When you produce something, just about anything, capital is ...

Rajgopal Nidamboor

Of archetypes, not stereotypes

It is not that devising technologies, or progress, is a ...

Dharmendra Khandal

Use technology wisely to save earth's treasures

Wildlife biologists are certainly getting inspired by our armed forces’ ...


William D. Green

Chairman & CEO, Accenture